Novogene Asia Pacific Center East and Africa adopts Olink® Discover HT know-how to speed up multi-omics analysis with subsequent technology proteomics

Novogene Asia Pacific Center East and Africa adopts Olink® Discover HT know-how to speed up multi-omics analysis with subsequent technology proteomics

[ad_1]

UPPSALA, Sweden, Nov. 06, 2023 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) at the moment introduced that Novogene Asia Pacific Center East and Africa (AMEA) has adopted the Olink Discover HT platform to ship superior next-generation proteomics know-how to the scientific neighborhood within the area.

Novogene is a number one supplier of genomic providers and options providing in depth subsequent technology sequencing (NGS) capability and bioinformatics experience. The addition of Olink Discover HT considerably will increase Novogene AMEA’s capabilities and high quality of multi-omics analysis providers choices. Olink Discover HT represents the cutting-edge in subsequent technology proteomics, permitting scientists to precisely measure over 5,400 proteins utilizing solely 2µl of pattern. By combining Olink PEA know-how with an NGS readout of relative protein concentrations, every totally validated assay produces unmatched specificity and sensitivity.

“The addition of the Olink Discover platform to the Novogene portfolio marks our dedication to delivering the newest multi-omics options to the scientific neighborhood in Asia Pacific, Center East and Africa area. By seamlessly integrating Olink’s proteomics know-how with our present capabilities in genomics, transcriptomics, metagenomics and epigenomics, we hope to assist researchers unlock a brand new layer of actionable information. This initiative will elevate our capacity to supply extraordinary insights into illness biology, paving the best way for extra impactful discoveries.” stated Justin Lee, Vice President of Novogene AMEA.

“We’re immensely happy to see Olink® Discover HT being utilised by Novogene, a number one multiomic service supplier, to supply their prospects with revolutionary analysis providers. With the incorporation of Olink know-how, Novogene and Olink will likely be even higher positioned to domestically assist analysis throughout a broad spectrum of therapeutic analysis fields, understanding human biology and enhancing future healthcare.” stated Andrea Ballagi, MD, PhD, Vice President Gross sales and Advertising and marketing Asia and Pacific Area, Olink Proteomics.

Olink know-how was designed to unlock the immense worth of proteomics at any scale. Utilized by researchers all over the world, Olink’s analysis options have been utilized throughout a variety of therapeutic areas to achieve deeper understanding of molecular pathways concerned within the improvement, development, and end result of illness. Now, with Olink Discover HT, Novogene AMEA will start providing high-throughput proteomics with industry-leading specificity, serving to their prospects unravel the intricate connections between genes, proteins, and illnesses.

Investor contact
Jan Medina, CFA

VP Investor Relations & Capital Markets

Cell: +1 617 802 4157

jan.medina@olink.com

Media contact

Michael B. Gonzales, PhD

VP International Advertising and marketing

Cell: +1 415 308 6467

michael.gonzales@olink.com

About

Olink Holding AB (publ) (Nasdaq: OLK) is an organization devoted to accelerating proteomics along with the scientific neighborhood, throughout a number of illness areas to allow new discoveries and enhance the lives of sufferers. Olink gives a platform of services and products that are deployed throughout main pharmaceutical corporations and main medical and tutorial establishments to deepen the understanding of real-time human biology and drive twenty first century healthcare via actionable and impactful science. The Firm was based in 2016 and is properly established throughout Europe, North America and Asia. Olink is headquartered in Uppsala, Sweden.

Ahead-Trying Statements

This press launch comprises specific or implied “forward-looking statements” as outlined below the Non-public Securities Litigation Reform Act of 1995 which can be based mostly on administration’s beliefs and assumptions and on data at present obtainable to administration. All statements contained on this launch aside from statements of historic reality are forward-looking statements. In some instances, you may determine forward-looking statements by the phrases “could,” “may,” “will,” “might,” “would,” “ought to,” “anticipate,” “intend,” “search,” “plan,” “outlook,” “goal,” “anticipate,” “imagine,” “estimate,” “predict,” “venture,” “potential,” “proceed,” “at present, “ongoing” or the adverse of those phrases or different comparable terminology, though not all forward-looking statements comprise these phrases. These statements contain dangers, uncertainties and different elements which will trigger precise outcomes, ranges of exercise, efficiency, or achievements to be materially completely different from the data expressed or implied by these forward-looking statements. These dangers, uncertainties and different elements are described below the caption “Danger Components” in our Kind 20-F for the fiscal yr ended December 31, 2022 (Fee file quantity 001-40277) and elsewhere within the paperwork we file with the Securities and Change Fee on occasion. We warning you that forward-looking statements are based mostly on a mix of details and elements at present identified by us and our projections for the longer term, about which we can’t be sure. In consequence, the forward-looking statements could not show to be correct. The forward-looking statements on this press launch characterize our views as of the date hereof. We undertake no obligation to replace any forward-looking statements for any cause, besides as required by legislation.



Primary Logo

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *